ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 22

$742K Total Retail Price of All Prescriptions

Rank: 4 out of 22

415 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 415 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 7,816 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 42%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $91 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METFORMIN HCL 476 408 1 3
SIMVASTATIN 469 417 2 4
ATORVASTATIN CALCIUM 423 362 3 11
LEVOTHYROXINE SODIUM 292 242 4 1
SYNTHROID 278 220 5 2
AMLODIPINE BESYLATE 261 247 6 13
LANTUS 245 183 7 8
FUROSEMIDE 225 198 8 25
LISINOPRIL 218 176 9 10
METOPROLOL TARTRATE 210 189 10 18
METFORMIN HCL ER 169 147 11 7
GLIMEPIRIDE 165 148 12 5
INSULIN SYRINGE 162 138 13 6
METOPROLOL SUCCINATE 154 132 14 50
ACTOS 136 108 15 47
METHIMAZOLE 133 101 16 30
PEN NEEDLE 131 112 17 9
OMEPRAZOLE 130 130 18 17
JANUVIA 128 119 19 14
LANTUS SOLOSTAR 123 96 20 15
LIPITOR 123 106 20 53
WARFARIN SODIUM 121 118 22 26
ONGLYZA 111 111 23 43
HYDROCHLOROTHIAZIDE 109 91 24 23
ENALAPRIL MALEATE 100 74 25 56
CLOPIDOGREL 98 79 26 93
LOSARTAN POTASSIUM 95 83 27 20
HUMALOG 94 71 28 16
GLIPIZIDE ER 85 85 29 24
PLAVIX 85 78 29 95
PAROXETINE HCL 81 78 31 72
BENAZEPRIL HCL 79 69 32 69
QUINAPRIL HCL 78 77 33 57
GLYBURIDE 74 64 R 34 45
GLIPIZIDE XL 72 55 35 39
ALENDRONATE SODIUM 70 69 36 32
NOVOLOG MIX 70-30 60 53 37 40
GLYBURIDE-METFORMIN HCL 60 54 R 37 42
ALLOPURINOL 57 57 39 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 57 39 60
HYDROCODONE-ACETAMINOPHEN 57 56 S3 39 22
PIOGLITAZONE HCL 55 42 R 42 64
HYDRALAZINE HCL 55 47 42 86
ISOSORBIDE MONONITRATE ER 55 55 42 87
DIOVAN 53 53 45 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.